Monovalent Recombinant COVID19 Vaccine
Clinical trial NCT04453852 · COMPLETED
Trial details
- NCT number
- NCT04453852
- Sponsor
- Vaxine Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2021-02-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.